País: Nova Zelanda
Idioma: anglès
Font: Ministry for Primary Industries
carprofen
Chanelle Pharmaceuticals Manufacturing Limited
carprofen
carprofen 133.85 g/kg
Anti-inflammatory
ACVM Registered
2015-06-22
CARTON RESTRICTED VETERINARY MEDICINE CANIDRYL FLAVOURED TABLETS FOR DOGS. ACTIVE SUBSTANCE ONE GRILLED MEAT FLAVOURED TABLET CONTAINS: Carprofen 20 mg/tablet Carprofen 50 mg/tablet INDICATION(S) For the relief of chronic and acute pain and inflammation in dogs. Read the package leaflet before use. Store in a dry place in the original package. Protect from light. Divided and unused tablets should be discarded immediately. Any unused product or waste material should be disposed of in accordance with local requirements. ACVM No. A11141 See www.foodsafety.govt.nz for registration c onditions. Registered to: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland Distributed by: Ethical Agents Veterinary Marketing, 54 Hobill Ave, Manukau, NZ Ph: 262 1388, Freephone 0800 800 624 Batch No: Expiry: BLISTERS Canidryl Flavoured Tablets for Dogs (20 mg, 50 mg, 100 mg) Carprofen (20 mg/tablet, 50 mg/tablet, 100 mg/tablet) RVM A11141 Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, IrelandLlegiu el document complet {number} For animal treatment only. PACKAGE LEAFLET (COMMON) RESTRICTED VETERINARY MEDICINE CANIDRYL FLAVOURED TABLETS FOR DOGS. ACTIVE SUBSTANCE ONE GRILLED MEAT FLAVOURED TABLET CONTAINS: Carprofen 20 mg/tablet Carprofen 50 mg/tablet Carprofen 100 mg/tablet INDICATION(S) For the relief of chronic and acute pain and inflammation in dogs. CONTRAINDICATIONS Do not use in cats. Do not use in pups less than 4 months of age. Do not use in case of hypersensitivity to active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. ADVERSE REACTIONS Typical undesirable effects associated with NSAIDs, such as vomiting, soft faeces/diarrhea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions occur generally within the first treatment week and are in most cases